MCRB
Seres Therapeutics Inc
2.70$
+3.0%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.5% | -4.8% | -5.7% | -44.4% | -21.8% | +17.4% | -12.4% | -0.2% | -3.7% | -14.9% | -13.6% | |
| – | -18.2% | -5.8% | -9.6% | -51.1% | -47.0% | +70.9% | -26.3% | +5.8% | -4.2% | -35.5% | +33.0% | |
| – | -24.7% | -13.1% | -35.9% | -6.2% | -53.9% | +91.1% | -22.9% | +5.0% | -3.9% | -34.8% | -47.7% | |
| – | -24.7% | -13.1% | -35.9% | -6.2% | -53.9% | +91.1% | -22.9% | +5.0% | -3.9% | -34.8% | -47.7% | |
| – | -48.5% | -14.5% | +150.8% | – | – | -7.7% | -79.9% | -11.9% | -53.7% | -35.3% | +10,747.2% | |
| – | +60.0% | +41.6% | +26.3% | – | – | – | – | – | – | – | – | |
| – | +5.4% | -0.6% | +1.9% | -62.1% | -18.6% | -9.8% | -2.5% | -10.0% | -5.8% | -3.0% | -26.4% | |
| – | +24.5% | -0.2% | +10.0% | -40.1% | -36.4% | -24.0% | -1.2% | -27.5% | -13.9% | +0.1% | +3.6% | |
| – | -11.0% | +58.1% | +4.1% | -9.2% | +3.9% | +4.3% | +4.7% | +4.7% | +4.7% | +4.6% | +8.9% | |
| – | -59.4% | +43.3% | -7.9% | +71.6% | -50.6% | -46.8% | +1.5% | -23.8% | +0.3% | +39.0% | -49.3% | |
| – | +0.4% | +0.5% | +0.5% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -42.4% | +266.1% | -34.7% | +32.6% | +1.2% | -40.1% | +30.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.8% | +13.0% | +3.7% | +0.7% | +13.3% | +0.7% | +0.3% | +0.3% | +1.1% | +8.0% | +0.6% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.